Cargando…
Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis
INTRODUCTION: The use of insulin analogs for the treatment of type 1 diabetes mellitus (T1DM) is widespread; however, the therapeutic benefits still require further evaluation given their higher costs. The objective of this study was to evaluate the effectiveness and safety of analog insulin glargin...
Autores principales: | Marra, Lays P., Araújo, Vania E., Silva, Thales B. C., Diniz, Leonardo M., Guerra Junior, Augusto A., Acurcio, Francisco A., Godman, Brian, Álvares, Juliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900976/ https://www.ncbi.nlm.nih.gov/pubmed/27048292 http://dx.doi.org/10.1007/s13300-016-0166-y |
Ejemplares similares
-
Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications
por: Almeida, Paulo H. R. F., et al.
Publicado: (2018) -
The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil
por: Maia Diniz, Isabela, et al.
Publicado: (2018) -
Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia(®)) in Brazil; Implications for Future Pricing Considerations
por: Godói, Isabella P., et al.
Publicado: (2017) -
Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective
por: Camelo, Ricardo Mesquita, et al.
Publicado: (2023) -
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
por: Lemos, Livia Lovato Pires de, et al.
Publicado: (2017)